Medication side effects among people with epilepsy taking phenobarbital in Zambia.
Ontology highlight
ABSTRACT: Phenobarbital remains one of the most widely used antiepileptic drugs worldwide, yet there are limited data regarding side effects associated with its use in routine clinical care settings in low-income countries. Available data suggests that phenobarbital is as effective as other first-line drugs for treating tonic-clonic seizures, but side effect reports differ widely between high and low-income settings. A better understanding of phenobarbital side effect profile and severity in low-income settings is warranted given its role in efforts to decrease the epilepsy treatment gap. We used the Liverpool adverse events profile (LEAP) to assess side effects in consecutive patients with epilepsy on phenobarbital seeking care in rural Zambia. Data regarding age, gender, medication dose, and medic
SUBMITTER: Elafros MA
PROVIDER: S-EPMC4194251 | biostudies-literature | 2014 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA